Precision BioSciences (DTIL) vs Yarrow Bioscience (YARW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Precision BioSciences (DTIL) has outperformed Yarrow Bioscience (YARW) over the past year, gaining 12.8% versus a loss of 7.6%. Over five years, DTIL leads with a -97.8% price change compared with -98.2% for YARW. Precision BioSciences is the larger company by market cap ($187.8 million vs $187.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DTIL | YARW |
|---|---|---|
| Share price | $6.81 | $20.13 |
| Market cap | $187.83M | $187.30M |
| 1-day change | +5.83% | +1.31% |
| YTD return | +54.57% | -31.48% |
| 1-year return | +12.81% | -7.58% |
| 5-year return | -97.81% | -98.19% |
| EPS (TTM) | $-1.35 | — |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.62 | $46.95 |
| 52-week low | $3.53 | $16.05 |
| Distance from 52-week high | -29.26% | -57.12% |
| Analyst consensus | none | none |
| Avg. price target upside | +332.04% | +183.16% |
| Average volume | 287.13K | 88.98K |
| Shares outstanding | 27.60M | 9.30M |
| Employees | 67 | 7 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DTIL has outperformed YARW by 20.4 percentage points over the past year.
About Precision BioSciences
DTIL stock →Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 67 employees
About Yarrow Bioscience
YARW stock →Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
DTIL vs YARW FAQ
Which is bigger, Precision BioSciences or Yarrow Bioscience?
Precision BioSciences (DTIL) is larger, with a market capitalization of $187.83M compared with $187.30M for Yarrow Bioscience (YARW).
Which stock has performed better over the past year, DTIL or YARW?
DTIL returned +12.81% over the past 12 months, compared with -7.58% for YARW (price return, excluding dividends). Past performance does not predict future results.
Are Precision BioSciences and Yarrow Bioscience in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Biological Products (No Diagnostic Substances) for Precision BioSciences and Biotechnology: Pharmaceutical Preparations for Yarrow Bioscience.